DEF: Healthpeak Properties Reports Solid 2025, Plans Senior Housing Spinoff

Healthpeak Properties, Inc. reports solid 2025 financial and operational performance, including a 4% same-store NOI growth, and announces the planned IPO of its senior housing portfolio as Janus Living, Inc.

Summary

• Completed the integration of platforms and people following the transformative merger with Physicians Realty Trust in 2024 and internalization of property management, creating a leading real estate platform dedicated to healthcare discovery and delivery with total portfolio investment of approximately $25 billion and 50 million square feet of Outpatient Medical and Lab properties.
• Achieved Net Income of $0.10 per common share for the year ended December 31, 2025.
• Delivered Nareit FFO of $1.81 per common share and FFO as Adjusted of $1.84 per common share for 2025.
• Realized Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of 4% for the year ended December 31, 2025.
• Achieved strong leasing with over 6.3 million square feet of new and renewal lease executions in 2025.
• Maintained a strong balance sheet with Net Debt to Adjusted EBITDAre of 5.2x (average of four quarters for 2025).
• Increased the annualized dividend to $1.22 per share ($0.305 per quarter) and moved to monthly dividend payments.
• Announced the formation and planned initial public offering (IPO) of Janus Living, Inc., a pure-play senior housing REIT, to which Healthpeak will contribute its senior housing portfolio and serve as its external manager, retaining a substantial majority interest.
• Executed executive succession planning in 2025, appointing Kelvin Moses as Chief Financial Officer and Tracy Porter as Executive Vice President and General Counsel.
• The 2025 Short-Term Incentive Plan (STIP) paid out above target levels due to solid financial, operational, and corporate impact performance.
• The 2023 Long-Term Incentive Plan (LTIP), covering the 2023-2025 performance period, paid out below the target level (10.4% blended overall payout) based on Total Stockholder Return (TSR) performance relative to defined peers.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to strong operational performance, strategic portfolio optimization through the Janus Living IPO, and robust governance, despite the below-target long-term equity incentive payout.

Positives

• Solid financial performance in 2025, with Net Income of $0.10 per share, Nareit FFO of $1.81 per common share, and FFO as Adjusted of $1.84 per common share.
• Strong Merger-Combined Same-Store Cash (Adjusted) NOI growth of 4% for 2025, including 12.6% growth in Senior Housing.
• High total leasing volume of 6.3 million square feet in 2025, demonstrating operational strength.
• Maintained a strong balance sheet with a Net Debt to Adjusted EBITDAre of 5.2x, reflecting financial discipline.
• Increased annualized dividend to $1.22 per share and transitioned to monthly dividend payments, benefiting shareholders.
• Strategic formation and planned IPO of Janus Living, Inc. is expected to unlock value in the senior housing portfolio.
• Successful executive succession planning with internal promotions of Kelvin Moses to CFO and Tracy Porter to EVP and General Counsel.
• Robust risk oversight, including an annual enterprise risk management assessment and engagement of a third-party expert for cybersecurity and technology risks.
• The 2025 Short-Term Incentive Plan (STIP) paid out above target levels, indicating strong achievement of internal financial, operational, and corporate impact goals.
• Continued advancement of a 10-year strategic sustainability roadmap, achieving 6 new or re-certified LEED certifications in 2025.
• Strong corporate governance practices, including 55% Board refreshment since 2023, an independent Board Chair, and robust stock ownership guidelines.

Negatives

• The 2023 Long-Term Incentive Plan (LTIP), covering the 2023-2025 performance period, paid out below the target level (10.4% blended overall payout) based on Total Stockholder Return (TSR) performance relative to defined peers.
• Performance-Based Awards for 2024-2026 and 2025-2027 are currently tracking below target as of December 31, 2025.
• Acknowledged a challenging supply/demand environment in the Lab sector.

Risks

• Changes to regulatory, funding, staffing, trade, and other policies and actions by the U.S. political administration.
• Macroeconomic trends that may increase borrowing, construction, labor, and other operating costs.
• Changes within the life science industry, and significant regulation, funding requirements, and uncertainty faced by lab tenants.
• Factors adversely affecting tenants, operators, or borrowers' ability to meet their financial and other contractual obligations.
• The insolvency or bankruptcy of one or more major tenants, operators, or borrowers.
• Concentration of real estate investments in the healthcare property sector, making the company more vulnerable to a downturn in that specific sector.
• The illiquidity of real estate investments.
• Ability to identify and secure new or replacement tenants and operators.
• Property development, redevelopment, and tenant improvement risks, which can render a project less profitable or unprofitable and delay or prevent its undertaking or completion.
• The ability of the hospitals on whose campuses outpatient medical buildings are located and their affiliated healthcare systems to remain competitive or financially viable.
• Operational risks associated with senior housing properties managed by third parties, including properties operated through RIDEA structures.
• The failure of tenants, operators, and borrowers to comply with federal, state, and local laws and regulations, including resident health and safety requirements, as well as licensure, certification, and inspection requirements.
• Required regulatory approvals to transfer senior housing properties.
• Compliance with the Americans with Disabilities Act and fire, safety, and other regulations.
• The requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid.
• Economic conditions, natural disasters, weather, and other conditions that negatively affect geographic areas where investments are concentrated.
• Uninsured or underinsured losses, which could result in a significant loss of capital invested in a property, lower than expected future revenues, and unanticipated expenses.
• Use of joint ventures may limit returns on and flexibility with jointly owned investments.
• Use of rent escalators or contingent rent provisions in leases.
• Competition for suitable healthcare properties to grow the investment portfolio.
• Ability to exercise rights on collateral securing real estate-related loans.
• Any requirement to recognize reserves, allowances, credit losses, or impairment charges.
• Investment of substantial resources and time in transactions that are not consummated.
• Ability to successfully integrate or operate acquisitions and/or internalize property management.
• The potential impact of unfavorable resolution of litigation or disputes and resulting rising liability and insurance costs.
• Environmental compliance costs and liabilities associated with real estate investments.
• Environmental, social, and governance (corporate impact) and sustainability commitments and changing requirements, as well as stakeholder expectations.
• Epidemics, pandemics, or other infectious diseases, and health and safety measures intended to reduce their spread.
• Past participation in the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) Provider Relief Fund and other Covid-related stimulus and relief programs.
• Laws or regulations prohibiting eviction of tenants.
• Human capital risks, including the loss or limited availability of key personnel.
• Reliance on information technology and any material failure, inadequacy, interruption, or security failure of that technology.
• The use of, or inability to use, artificial intelligence by the company, its tenants, its vendors, and its investors.
• Volatility, disruption, or uncertainty in the financial markets.
• Increased interest rates and borrowing costs, which could impact the ability to refinance existing debt, sell properties, and conduct investment activities.
• Cash available for distribution to stockholders and ability to make dividend distributions at expected levels.
• The availability of external capital on acceptable terms or at all.
• An increase in the level of indebtedness.
• Covenants in debt instruments, which may limit operational flexibility, and breaches of these covenants.
• Volatility in the market price and trading volume of common stock.
• Adverse changes in credit ratings.
• The pending Janus Living Offering may not be completed on the currently contemplated timeline or terms, or at all, and may not achieve the intended benefits.
• Economic exposure to shifts in the price of Janus Living common stock and ability to control the assets and activities of Janus Living.
• Potential conflicts of interest in the relationship with Janus Living.
• Ability to maintain qualification as a real estate investment trust (REIT).
• Taxable REIT subsidiaries being subject to corporate level tax.
• Tax imposed on any net income from prohibited transactions.
• Changes to U.S. federal income tax laws, and potential deferred and contingent tax liabilities from corporate acquisitions.
• Calculating non-REIT tax earnings and profits distributions.
• Tax protection agreements that may limit ability to dispose of certain properties and may require maintaining certain debt levels.
• Ownership limits in the charter that restrict ownership in stock, and provisions of Maryland law and the charter that could prevent a transaction that may otherwise be in the interest of stockholders.
• Conflicts of interest between the interests of stockholders and the interests of holders of Healthpeak OP, LLC (Healthpeak OP) common units.
• Provisions in the operating agreement of Healthpeak OP and other agreements that may delay or prevent unsolicited acquisitions and other transactions.
• Status as a holding company of Healthpeak OP.

Future Outlook

The company plans the initial public offering of Janus Living, Inc., a pure-play senior housing REIT, to unlock value in its senior housing portfolio. Healthpeak will contribute its senior housing portfolio to Janus Living and serve as its external manager, intending to retain a substantial majority interest immediately following the IPO. For 2026, executive compensation structure changes include extending the Long-Term Incentive Plan (LTIP) performance period from three to five years with a one-year post-vesting holding period and a 110% multiplier on payout. Additionally, executives will have the option to receive 2026 Short-Term Incentive Plan (STIP) bonuses in profits interest units or RSUs with a 120% multiplier.

Management Comments

• "We are committed to delivering long-term value for you and governing Healthpeak in a prudent and transparent manner."
• "Our executive team continued to drive strong operational results across the entire portfolio in 2025."
• "We believe this strategic transaction [Janus Living IPO] will unlock value in our senior housing portfolio and benefit our stockholders in the long term."
• "We are excited about Healthpeak's achievements in 2025 and believe we are well positioned for long-term growth."
• "Our executive compensation program aligns with our corporate strategy and incentivizes delivering long-term value for stockholders."
• "Pay-for-performance alignment is reflected in our incentive plan results: Our short-term incentive plan (STIP) results paid out above the target level as a result of achieving solid 2025 financial and operational performance results, as well as strong individual performance and contributions."
• "Our performance-based long-term incentive plan (LTIP) awards paid out below the target level based on total stockholder return (TSR) performance for 2023-2025 relative to defined peers."
• "We believe that our compensation program provides compelling incentives for our executives, which in turn benefits our stockholders by driving our business strategy and goals."

Industry Context

StockSavvy.ai notes that Healthpeak's strategic move to spin off its senior housing portfolio into Janus Living, Inc. aligns with a broader industry trend among diversified REITs to streamline portfolios and focus on core, high-growth segments like lab and outpatient medical. This specialization can enhance market valuation by providing clearer investment profiles. The strong performance in outpatient medical and senior housing NOI growth, contrasted with a challenging supply/demand environment in the Lab sector, reflects varied dynamics within the healthcare real estate market. The company's emphasis on investment-grade credit ratings and a strong balance sheet is crucial in a rising interest rate environment, positioning it favorably against competitors with higher leverage.

Comparison to Industry Standards

• Healthpeak's 4% Merger-Combined Same-Store Cash (Adjusted) NOI growth for 2025 is competitive within the healthcare REIT sector, particularly with 12.6% growth in Senior Housing, which outperforms many peers struggling with post-pandemic recovery.
• The 5.2x Net Debt to Adjusted EBITDAre is a strong leverage metric, comparing favorably to some diversified REITs that may have higher leverage ratios, demonstrating financial discipline.
• The below-target payout for the 2023-2025 LTIP based on TSR performance indicates that while operational metrics were strong, the stock's total return lagged some defined peers, suggesting a potential disconnect between internal performance and market perception or broader sector headwinds.

Management Changes

Corporate Governance

Related Party Transactions

• Anticipated that the Audit Committee will approve certain related party transactions with Janus Living, including that each of Messrs. Brinker, Moses, Mabry, and Patadia, and Ms. Porter will receive equity awards from, and enter into an indemnification agreement with, Janus Living in connection with the provision of services to Janus Living.
• Healthpeak non-employee directors are anticipated to receive a one-time grant of equity awards from Janus Living in amounts yet to be determined.
• Ms. Sandstrom is anticipated to receive compensation from, and enter into an indemnification agreement with, Janus Living for her services as a non-employee director of that company.

Stakeholder Impact

• Shareholders: Potential for long-term value creation through strategic portfolio optimization (Janus Living IPO), increased dividends, and strong corporate governance. Risk of underperformance in long-term equity awards if TSR lags peers.
• Employees: Focus on a people-first culture, employee engagement, development, and well-being programs. Executive succession planning promotes internal candidates and career advancement.
• Customers/Tenants: Commitment to developing and owning high-quality, irreplaceable healthcare real estate and being the real estate partner of choice to biopharma and health system tenants.
• Management: Compensation aligned with performance, with a significant portion at risk. Robust succession planning and development opportunities are provided.
• Regulatory Authorities: Commitment to robust risk oversight and compliance with SEC, NYSE, and other regulatory requirements, including transparent disclosures.

Next Steps

• Annual Meeting of Stockholders on April 30, 2026, to elect nine directors, approve 2025 executive compensation on an advisory basis, and ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026.
• Completion of the initial public offering of Janus Living, Inc.
• Appointment of Ms. Lias-Booker and Mr. Weiss to the Audit Committee, and Mr. Connor to the Investment and Finance Committee as Chair, following the Annual Meeting.
• Ongoing review of the director compensation program for continued alignment with comparable companies and sound governance practices.
• Implementation of 2026 executive compensation plans, including an extended LTIP performance period and the option for STIP bonuses in equity.
• Annual enterprise risk management assessment.
• Continued advancement of the 10-year strategic sustainability roadmap.
• Annual review of director time commitments and compliance.
• Annual self-assessment of the Board.
• Annual review of Codes of Conduct.
• Annual testing of executive stock ownership guidelines on March 1.
• The next advisory vote on executive compensation is expected at the 2027 annual meeting.

Key Dates

Recommendation

Healthpeak Properties demonstrates solid operational performance and a clear strategic direction with the planned Janus Living IPO, which could unlock value. The strong balance sheet and commitment to corporate governance are positives. However, the below-target payout for the 2023-2025 LTIP based on TSR indicates that market performance has lagged some peers, and the 'tracking below target' for current LTIPs suggests continued challenges in stock performance relative to the market. Given the mixed signals of strong internal operations but lagging market-based returns, a 'hold' recommendation is appropriate for investors to observe the execution of the Janus Living spin-off and its impact on overall valuation and long-term TSR.

Keywords

Healthcare REIT, Real Estate, Lab Properties, Outpatient Medical, Senior Housing, Janus Living, IPO, Corporate Governance, Executive Compensation, Risk Management, Sustainability, Dividends, Acquisitions, Development, Financial Performance, FFO, EBITDAre, Total Stockholder Return, SEC Filing